Ceva Animal Health Partners with Touchlight to Use its dbDNA Technology in Animal Healthcare
Shots:
- Ceva & Touchlight entered into an agreement & long-term collaboration for developing & manufacturing future animal health products, integrating the former’s development & marketing expertise with Touchlight’s dbDNA tech to develop DNA vaccines
- As per the agreement, Touchlight is entitled to upfront payment, development milestones & sales-based royalties, while the complete financial terms remain undisclosed
- Touchlight’s doggybone DNA or dbDNA technology utilizes a synthetic DNA vector allowing rapid, scalable & high purity production of DNA essential to the development of genetic medicines
Ref: Ceva| Image: Ceva & Touchlight
Related News:- PettureX Reports the Launch of AI Pet Health Scanner App, Addressing Pet Health
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
